FOLLOW-UP: OBSERVATION VS. THERAPY
Patients with Pap smears interpreted as LSIL may
if reliable and have the ability to be followed, may be followed by
repeat smears at 4 to 6 months.
A meta-analysis of women with LSIL Pap tests had
a pooled rate of regression reported as 47.39%, with a very low
risk of invasive carcinoma, varying from 0.00% to
Melnikow J et al. Obstet Gyne 1998;92:727-35